2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
To describe clinical outcomes of both Y-90 RS and EBRT as initial therapy for solitary HCC.
This video is sponsored by Boston Scientific.
Related Content: